Vivek Subbiah: Bringing clinical trials to patients close to home
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:
“Clinical trials are the foundation of progress in cancer care, and it’s through our collective dedication and collaboration that we continue to make significant strides.
At Sarah Cannon Research Institute we are committed to bringing clinical trials to patients close to home, offering hope to those who need it most.
What makes clinical trials so powerful? They bring together diverse teams and unite them under a common goal—finding better, more personalized treatments. Every step we take is driven by unity, passion, and the relentless pursuit of progress.
Let’s keep the conversation going—Dr. Dave Buck I’d love to hear your thoughts on the future of cancer care and the role of clinical trials in shaping that future.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023